These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31324209)

  • 1. Development of the IRIS-AR strategy: an intervention to improve rates of accrual and retention for the VTE-PRO randomized controlled trial.
    Fahim C; Hylton D; Simunovic M; Agzarian J; Finley C; Hanna WC; Shargall Y
    Trials; 2019 Jul; 20(1):447. PubMed ID: 31324209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perception of Chemical Venous Thromboprophylaxis for Oncologic Lung Resections among Thoracic Surgeons.
    Malgor RD; Bilfinger TV; Blebea J; Ma H; Arnold SR
    Ann Vasc Surg; 2017 Oct; 44():299-306. PubMed ID: 28479450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial.
    Rodger MA; Phillips P; Kahn SR; James AH; Konkle BA;
    Thromb Haemost; 2015 Jan; 113(1):212-6. PubMed ID: 25373438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer.
    Hachey KJ; Hewes PD; Porter LP; Ridyard DG; Rosenkranz P; McAneny D; Fernando HC; Litle VR
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):37-44.e1. PubMed ID: 26386868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
    Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous Thromboembolism Incidence and Prophylaxis Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized Clinical Trial.
    Jung YJ; Seo HS; Park CH; Jeon HM; Kim JI; Yim HW; Song KY
    JAMA Surg; 2018 Oct; 153(10):939-946. PubMed ID: 30027281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboprophylaxis in oesophageal cancer patients-a study protocol for a randomised, controlled trial (TOP-RCT).
    Gyldenholm T; Madsen N; Katballe N; Kjær DW; Christensen TD; Hvas AM
    Trials; 2024 Sep; 25(1):591. PubMed ID: 39242497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.
    Kaatz S; Spyropoulos AC
    Hosp Pract (1995); 2011 Aug; 39(3):7-15. PubMed ID: 21881387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
    van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
    Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the elderly.
    Kozek-Langenecker S; Fenger-Eriksen C; Thienpont E; Barauskas G;
    Eur J Anaesthesiol; 2018 Feb; 35(2):116-122. PubMed ID: 28901992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caprini Risk Model Decreases Venous Thromboembolism Rates in Thoracic Surgery Cancer Patients.
    Sterbling HM; Rosen AK; Hachey KJ; Vellanki NS; Hewes PD; Rao SR; Pinjic E; Fernando HC; Litle VR
    Ann Thorac Surg; 2018 Mar; 105(3):879-885. PubMed ID: 29397103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial.
    Alalaf SK; Jawad RK; Muhammad PR; Ali MS; Al Tawil NG
    BMC Pregnancy Childbirth; 2015 Mar; 15():72. PubMed ID: 25884460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Techniques to Enhance rEtention in Randomised controlled trials: the STEER study protocol.
    Gillies K; Bower P; Elliott J; MacLennan G; Newlands RSN; Ogden M; Treweek SP; Wells M; Witham MD; Young B; Francis JJ
    Trials; 2018 Mar; 19(1):197. PubMed ID: 29580260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survey of current status of prevention of venous thromboembolism after thoracic surgery in China].
    Song CF; Li H; Tian B; Chen S; Miao JB; Fu YL; You B; Hu B
    Zhonghua Wai Ke Za Zhi; 2017 Sep; 55(9):661-666. PubMed ID: 28870050
    [No Abstract]   [Full Text] [Related]  

  • 17. A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods study.
    Smith JD; Baillie J; Baglin T; Griffiths GO; Casbard A; Cohen D; Fitzmaurice DA; Hood K; Rose P; Cohen AT; Johnson M; Maraveyas A; Bell J; Toone H; Nelson A; Noble SI
    Trials; 2014 Apr; 15():122. PubMed ID: 24726032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin prophylaxis 24 to 36 hours after degenerative spine surgery: risk of hemorrhage and venous thromboembolism.
    Strom RG; Frempong-Boadu AK
    Spine (Phila Pa 1976); 2013 Nov; 38(23):E1498-502. PubMed ID: 23873245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients.
    Dobesh P
    Int J Clin Pract; 2010 Oct; 64(11):1554-1562. PubMed ID: 20846203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.